Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Value of Screening and Treatment of Sleep Apnea-Hypopnea Syndrome in the Management of Atrial Fibrillation Ablation Candidates

NCT04606693 is registered in ClinicalTrials.gov with Hospital San Carlos, Madrid as lead sponsor.

NCT NCT04606693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04606693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Value of Screening and Treatment of Sleep Apnea-Hypopnea Syndrome in the Management of Atrial Fibrillation Ablation Candidates
Lead sponsor
Hospital San Carlos, Madrid
Phase
Not applicable
Overall status
Recruiting
Start date
November 5, 2020
Completion date
December 31, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

apnea syndrome, atrial fibrillation paroxysmal, atrial fibrillation, persistent, hypopnea syndrome